CCCC 8-K 2026-09-25

C4 Therapeutics, Inc. (CCCC) 8-K dated 2026-09-25 — accession 0001628280-26-063497. This URL is the filing, not the CCCC hub.

C4 Therapeutics, Inc. (CCCC) is a biotechnology company listed on US.

C4 Therapeutics, Inc. filed a 8-K on 2026-09-25. Accession 0001628280-26-063497.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CCCC revenue for 2025-12-31 was $35.9M. Net income was -$105.0M. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. CCCC currently screens at market cap $425.7M.

Not investment advice. The CCCC SEC hub lists recent forms. The stock page is the research view.